Small intestinal mucosal injury and its risk factors in patients with gastrointestinal cancer who developed complicated fluoropyrimidine-induced diarrhea

Small intestinal mucosal injury and its risk factors in patients with gastrointestinal cancer who developed complicated fluoropyrimidine-induced diarrhea

Abstract Background Diarrhea is a common adverse event of fluoropyrimidine-based chemotherapy. However, limited data are available on the frequency and risk factors of complicated chemotherapy-induced diarrhea (CID) and small intestinal mucosal damage. In this current study, we aimed to determine th...

Full description

Bibliographic Details
Main Authors: Miho Sakumura, Takayuki Ando, Ayumu Hosokawa, Takahiko Nakajima, Iori Motoo, Hiroshi Mihara, Akira Ueda, Shinya Kajiura, Sohachi Nanjo, Haruka Fujinami, Kohei Ogawa, Ichiro Yasuda
Format: Article
Language:English
Published: BMC 2020-10-01
Series:BMC Gastroenterology
Subjects:
Mucosal injury
Gastrointestinal cancer
Chemotherapy
Fluoropyrimidine
Chemotherapy-induced diarrhea
Online Access:http://link.springer.com/article/10.1186/s12876-020-01507-5

Internet

http://link.springer.com/article/10.1186/s12876-020-01507-5

Similar Items